Faculty Opinions recommendation of Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 188
(1)
◽
pp. 110-111
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):